Table 2.
Treatments | 6 h | 24 h | 48 h | 72 h |
---|---|---|---|---|
BSS | 100 ± 4.06 | 100 ± 3.45 | 100 ± 3.14 | 100 ± 2.25 |
Reg P. –Ab | 88.7 ± 4.32 | 65.7 ± 3.87 | 51.3 ± 3.65 | 30.1 ± 3.14 |
Reg_P +Ab | 78.3 ± 4.98 | 58.3 ± 4.01 | 42.7 ± 3.49 | 21.3 ± 2.68 |
Dil_P –Ab | 92.7 ± 5.32 | 82.7 ± 4.87 | 58.3 ± 2.87 | 50.1 ± 2.98 |
Dil_P +Ab | 85.5 ± 3.24 | 75.6 ± 2.54 | 51.1 ± 4.21 | 45.7 ± 3.65 |
Reg P., regular proparacaine (0.5%); Dil. P, diluted proparacaine (0.05%); +Ab treated with antibiotics; −Ab not treated with antibiotics. At 6 h, viability was significantly affected, P < 0.01 (in Reg. P); and at 24, 48, and 72 h, the cellular viability was significantly affected, P < 0.001 (in Reg. P and Dil. P).